Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy

This document is an administrative response-to-comments notice for MolDX LCD L39711 (molecular biomarkers for risk stratification of indeterminate pulmonary nodules following bronchoscopy) and provides the comment period (2023-08-31 to 2023-10-14), notice start (2024-08-08), and effective date (2024-09-22). The document does not contain clinical coverage criteria; refer to LCD L39711 for specific indications, limitations, documentation requirements, and frequency limits.

"Administrative response-to-comments notice referencing MolDX LCD L39711 (Molecular biomarkers for risk stratification of indeterminate pulmonary nodules following bronchoscopy); comment period 2023..."

Sign up to see full coverage criteria, indications, and limitations.